Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,176.00p on 10-04-2026 at 18:20:07
Change 9.00p 0.42%
Buy 2,175.00p
Sell 2,174.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 178.00 at 2,176.00p
Day's Volume: 8,127,125
Last Close: 2,176.00p
Open: 2,156.00p
ISIN: GB00BN7SWP63
Day's Range 2,156.00p - 2,196.00p
52wk Range: 1,305.00p - 2,282.00p
Market Capitalisation: £86.96b
VWAP: 2,174.42851p
Shares in Issue: 4.00b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 178 2,176.00p SI Trade
Negotiated Trade
 16:48:16 - 10-Apr-26
Buy* 1,549 2,176.00p SI Trade
Negotiated Trade
 16:48:16 - 10-Apr-26
Sell* 1,956 2,176.00p Automatic Execution
 16:39:10 - 10-Apr-26
Sell* 1,955 2,176.00p Automatic Execution
 16:36:25 - 10-Apr-26
Buy* 1,200 2,176.00p Automatic Execution
 16:35:55 - 10-Apr-26
Buy* 300 2,176.00p Automatic Execution
 16:35:55 - 10-Apr-26
Buy* 400 2,176.00p Automatic Execution
 16:35:55 - 10-Apr-26
Buy* 100 2,176.00p Automatic Execution
 16:35:55 - 10-Apr-26
Buy* 400 2,176.00p Automatic Execution
 16:35:55 - 10-Apr-26
Buy* 1,700 2,176.00p Automatic Execution
 16:35:45 - 10-Apr-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
10th Apr 2026 (Fri) 2,156.00 2,196.00 2,156.00 2,176.00 8,127,125
9th Apr 2026 (Thu) 2,141.00 2,167.00 2,124.00 2,167.00 6,632,002
8th Apr 2026 (Wed) 2,126.00 2,142.00 2,104.00 2,125.00 9,481,975
7th Apr 2026 (Tue) 2,129.00 2,137.00 2,083.00 2,096.00 5,857,080
6th Apr 2026 (Mon) 2,144.00 2,144.00 2,144.00 2,144.00 0
3rd Apr 2026 (Fri) 2,144.00 2,144.00 2,144.00 2,144.00 0
2nd Apr 2026 (Thu) 2,097.00 2,161.00 2,090.00 2,144.00 6,448,889
1st Apr 2026 (Wed) 2,072.00 2,122.00 2,072.00 2,107.00 6,204,094
31st Mar 2026 (Tue) 2,064.00 2,086.00 2,064.00 2,064.00 15,704,368
30th Mar 2026 (Mon) 2,051.00 2,070.00 2,044.00 2,063.00 9,872,668
27th Mar 2026 (Fri) 2,041.00 2,060.00 2,023.00 2,049.00 6,240,777
26th Mar 2026 (Thu) 2,035.00 2,072.00 2,035.00 2,047.00 12,704,366
25th Mar 2026 (Wed) 1,991.50 2,054.00 1,989.50 2,054.00 11,609,628
24th Mar 2026 (Tue) 1,943.50 1,977.00 1,933.00 1,977.00 7,832,345
23rd Mar 2026 (Mon) 1,926.00 1,966.50 1,906.50 1,937.00 12,420,260
20th Mar 2026 (Fri) 1,960.00 1,967.50 1,940.50 1,950.50 14,988,054
19th Mar 2026 (Thu) 1,951.50 1,976.00 1,943.50 1,956.00 7,174,578
18th Mar 2026 (Wed) 2,010.00 2,013.00 1,945.50 1,972.50 8,290,930
17th Mar 2026 (Tue) 2,032.00 2,037.00 2,002.00 2,013.00 11,964,583
16th Mar 2026 (Mon) 2,037.00 2,053.00 2,026.00 2,026.00 6,815,220
13th Mar 2026 (Fri) 2,029.00 2,062.00 2,027.00 2,031.00 8,608,847
12th Mar 2026 (Thu) 2,053.00 2,057.00 2,015.00 2,031.00 7,904,164
11th Mar 2026 (Wed) 2,063.00 2,077.00 2,046.00 2,066.00 4,932,959
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
10th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
10th Apr 2026 7:00 am RNS Transaction in Own Shares
9th Apr 2026 3:30 pm RNS Director/PDMR Shareholding
9th Apr 2026 7:00 am RNS Transaction in Own Shares
8th Apr 2026 7:00 am RNS Exdensur approved for CRSwNP in China
8th Apr 2026 7:00 am RNS Transaction in Own Shares
7th Apr 2026 7:00 am RNS Transaction in Own Shares
2nd Apr 2026 7:00 am RNS Transaction in Own Shares
1st Apr 2026 3:30 pm RNS Director/PDMR Shareholding
1st Apr 2026 3:00 pm RNS Total Voting Rights
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: Oil creeps higher amid fragile US-Iran ceasefire

9th Apr 2026 17:07

(Alliance News) - The FTSE 100 nursed modest losses on Thursday as doubts grew over the strength and sustainability of the US-Iran ceasefire. Read More

China approves GSK's Exdensur for treating chronic rhinosinusitis

8th Apr 2026 08:59

(Alliance News) - GSK PLC on Wednesday said its Exdensur drug, has been approved in China as an add-on therapy for the treatment of chronic rhinosinusitis with nasal polyps. Read More

LONDON BRIEFING: Shell trims output view but refining margins climb

8th Apr 2026 07:50

(Alliance News) - Shell says the Middle East conflict hit output in its Integrated Gas arm, though it sees "significantly higher" trading and optimisation results. GSK announces a drug approval in China, while Close Brothers believes the cost of the final motor finance redress can be "comfortably absorbed". Read More

UK dividends calendar - next 7 days

2nd Apr 2026 12:07

Read More

Shionogi completes purchase of Pfizer stake in GSK's ViiV Healthcare

1st Apr 2026 09:18

(Alliance News) - GSK PLC and Shionogi & Co Ltd on Wednesday said the replacement of Pfizer Inc's stake in the ViiV Healthcare Ltd joint venture with an equal investment by Shionogi has been completed. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,600.53
Change-2.95

Login to your account

Forgot Password?

Not Registered